Cross-Sectional Study of Chronic Obstructive Pulmonary Disease Prevalence Among Smokers, Ex-Smokers, and Never-Smokers in Almaty, Kazakhstan: Study Protocol

Almaz Sharman, Baurzhan Zhussupov, Dana Sharman, Assel Stambekova, Sattar Yeraliyev, Almaz Sharman, Baurzhan Zhussupov, Dana Sharman, Assel Stambekova, Sattar Yeraliyev

Abstract

Background: Chronic obstructive pulmonary disease (COPD) is significantly underdiagnosed in Kazakhstan, and there is no previously conducted study on COPD prevalence in the country.

Objective: The purpose of this study is to assess the prevalence of COPD among individuals aged 40 to 59 years based on results of spirometry before and after bronchodilator, presence of structural changes in the lungs (emphysema, inflammatory changes, and thickening of the walls of the large and small airways) detected by computer tomography, and the symptoms of COPD. The study has 3 study groups: smokers of conventional cigarettes, those who had quit smoking 1 to 5 years ago, and those who haven't smoked cigarettes.

Methods: This is an observational study with a cross-sectional design among individuals aged 40 to 59 years in Almaty, Kazakhstan. The sample of 900 individuals of both sexes contains 500 smokers, 200 ex-smokers, and 200 never-smokers. Study measures include spirometry, chest computed tomography, electrocardiography, physical exams, laboratory testing of serum, anthropometry, and 6-minute walk test. Data are collected by computer-assisted personal interviewing with tablets. The questionnaire was designed to explore possible COPD risk factors including history of smoking, current smoking, level of smoking exposure (in pack-years), passive smoking, occupational and environmental hazards, and covariates: age, gender, ethnicity, education, occupation, and self-reported morbidity. COPD Assessment Test (CAT) is used to collect information about COPD symptoms.

Results: We have completed the participant recruitment and study procedures. Currently, we are working on data processing and data analysis. The authors anticipate the preliminary results should be available by September 2017. Study results will be published in peer-reviewed scientific journals.

Conclusions: This is the first study in Kazakhstan that assesses prevalence of COPD and its comorbidities in the adult population aged 40 to 59 years. The results of the study will be useful for improving COPD preventive measures, better COPD screening, identification, and registration. Findings of the study will also contribute to global knowledge on the epidemiology of COPD.

Trial registration: ClinicalTrials.gov NCT02926534; https://ichgcp.net/clinical-trials-registry/NCT02926534 (Archived by WebCite at http://www.webcitation.org/6rjwGsPOZ).

Keywords: COPD; Kazakhstan; cross-sectional; study protocol; tobacco smoking, risk factors.

Conflict of interest statement

Conflicts of Interest: None declared.

©Almaz Sharman, Baurzhan Zhussupov, Dana Sharman, Assel Stambekova, Sattar Yeraliyev. Originally published in JMIR Research Protocols (http://www.researchprotocols.org), 25.07.2017.

Figures

Figure 1
Figure 1
Patient recruitment, enrollment, and data collection and sharing.

References

    1. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Barker-Collo S, Bartels DH, Bell ML, Benjamin EJ, Bennett D, Bhalla K, Bikbov B, Bin AA, Birbeck G, Blyth F, Bolliger I, Boufous S, Bucello C, Burch M, Burney P, Carapetis J, Chen H, Chou D, Chugh SS, Coffeng LE, Colan SD, Colquhoun S, Colson KE, Condon J, Connor MD, Cooper LT, Corriere M, Cortinovis M, Couser W, Cowie BC, Criqui MH, Cross M, Dabhadkar KC, Dahodwala N, Degenhardt L, Delossantos A, Denenberg J, Dharmaratne SD, Dorsey ER, Driscoll T, Duber H, Ebel B, Erwin PJ, Espindola P, Ezzati M, Feigin V, Flaxman AD, Forouzanfar MH, Fowkes FGR, Franklin R, Fransen M, Freeman MK, Gabriel SE, Gakidou E, Gaspari F, Gillum RF, Gonzalez-Medina D, Halasa YA, Haring D, Harrison JE, Havmoeller R, Hay RJ, Hoen B, Hotez PJ, Hoy D, Jacobsen KH, James SL, Jasrasaria R, Jayaraman S, Johns N, Karthikeyan G, Kassebaum N, Keren A, Khoo J, Knowlton LM, Kobusingye O, Koranteng A, Krishnamurthi R, Lipnick M, Lipshultz SE, Ohno SL, Mabweijano J, MacIntyre MF, Mallinger L, March L, Marks GB, Marks R, Matsumori A, Matzopoulos R, Mayosi BM, McAnulty JH, McDermott MM, McGrath J, Mensah GA, Merriman TR, Michaud C, Miller M, Miller TR, Mock C, Mocumbi AO, Mokdad AA, Moran A, Mulholland K, Nair MN, Naldi L, Narayan KMV, Nasseri K, Norman P, O'Donnell M, Omer SB, Ortblad K, Osborne R, Ozgediz D, Pahari B, Pandian JD, Rivero AP, Padilla RP, Perez-Ruiz F, Perico N, Phillips D, Pierce K, Pope CA, Porrini E, Pourmalek F, Raju M, Ranganathan D, Rehm JT, Rein DB, Remuzzi G, Rivara FP, Roberts T, Rosenfeld LC, Rushton L, Sacco RL, Salomon JA, Sampson U, Sanman E, Schwebel DC, Segui-Gomez M, Shepard DS, Singh D, Singleton J, Sliwa K, Smith E, Steer A, Taylor JA, Thomas B, Tleyjeh IM, Towbin JA, Truelsen T, Undurraga EA, Venketasubramanian N, Vijayakumar L, Vos T, Wagner GR, Wang M, Wang W, Watt K, Weinstock MA, Weintraub R, Wilkinson JD, Woolf AD, Wulf S, Yeh P, Yip P, Zabetian A, Zheng Z, Lopez AD, Murray CJL, AlMazroa MA, Memish ZA. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012 Dec 15;380(9859):2095–2128. doi: 10.1016/S0140-6736(12)61728-0.
    1. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet. 1997 May 24;349(9064):1498–1504. doi: 10.1016/S0140-6736(96)07492-2.
    1. Chuchalin AG, Khaltaev N, Antonov NS, Galkin DV, Manakov LG, Antonini P, Murphy M, Solodovnikov AG, Bousquet J, Pereira MHS, Demko IV. Chronic respiratory diseases and risk factors in 12 regions of the Russian Federation. Int J Chron Obstruct Pulmon Dis. 2014;9:963–974. doi: 10.2147/COPD.S67283. doi: 10.2147/COPD.S67283.
    1. Adeloye D, Chua S, Lee C, Basquill C, Papana A, Theodoratou E, Nair H, Gasevic D, Sridhar D, Campbell H, Chan KY, Sheikh A, Rudan I. Global and regional estimates of COPD prevalence: systematic review and meta-analysis. J Glob Health. 2015 Dec;5(2):020415. doi: 10.7189/jogh.05-020415.
    1. National Center for the Problems of Forming the Healthy Lifestyle: press release. [2017-07-06]. .
    1. Global Initiative for Chronic Obstructive Lung Disease Global strategy for the diagnosis, management, and prevention of COPD. [2017-01-25].
    1. Swanney MP, Ruppel G, Enright PL, Pedersen OF, Crapo RO, Miller MR, Jensen RL, Falaschetti E, Schouten JP, Hankinson JL, Stocks J, Quanjer PH. Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction. Thorax. 2008 Dec;63(12):1046–1051. doi: 10.1136/thx.2008.098483.
    1. Bakke PS, Rönmark E, Eagan T, Pistelli F, Annesi-Maesano I, Maly M, Meren M, Vermeire DP, Vestbo J, Viegi G, Zielinski J, Lundbäck B. Recommendations for epidemiological studies on COPD. Eur Respir J. 2011 Dec;38(6):1261–1277. doi: 10.1183/09031936.00193809.
    1. Lundbäck B, Stjernberg N, Nyström L, Forsberg B, Lindström M, Lundbäck K, Jönsson E, Rosenhall L. Epidemiology of respiratory symptoms, lung function and important determinants. Report from the Obstructive Lung Disease in Northern Sweden Project. Tuber Lung Dis. 1994 Apr;75(2):116–126. doi: 10.1016/0962-8479(94)90040-X.
    1. Bakke P, Eide GE, Hanoa R, Gulsvik A. Occupational dust or gas exposure and prevalences of respiratory symptoms and asthma in a general population. Eur Respir J. 1991 Mar;4(3):273–278.
    1. Koff RS. Fundamentals of lung auscultation. N Engl J Med. 2014 May 22;370(21):2053. doi: 10.1056/NEJMc1403766#SA3.
    1. Make BJ, Martinez FJ. Assessment of patients with chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2008 Dec 15;5(9):884–890. doi: 10.1513/pats.200808-093QC.
    1. Pistolesi M, Camiciottoli G, Paoletti M, Marmai C, Lavorini F, Meoni E, Marchesi C, Giuntini C. Identification of a predominant COPD phenotype in clinical practice. Respir Med. 2008 Mar;102(3):367–376. doi: 10.1016/j.rmed.2007.10.019.
    1. Lynch DA, Austin JHM, Hogg JC, Grenier PA, Kauczor H, Bankier AA, Barr RG, Colby TV, Galvin JR, Gevenois PA, Coxson HO, Hoffman EA, Newell JD, Pistolesi M, Silverman EK, Crapo JD. CT-definable subtypes of chronic obstructive pulmonary disease: a statement of the Fleischner Society. Radiology. 2015 Oct;277(1):192–205. doi: 10.1148/radiol.2015141579.
    1. Mohamed HFAA, Zanen P, Gietema H, Kruitwagen CLJJ, Isgum I, Mol C, Dijkstra AE, Groen HJM, Boezen HM, Postma DS, Prokop M, Lammers JJ. CT-quantified emphysema in male heavy smokers: association with lung function decline. Thorax. 2011 Sep;66(9):782–787. doi: 10.1136/thx.2010.145995.
    1. Koo H, Jin KN, Kim DK, Chung HS, Lee C. Association of incidental emphysema with annual lung function decline and future development of airflow limitation. Int J Chron Obstruct Pulmon Dis. 2016;11:161–166. doi: 10.2147/COPD.S96809. doi: 10.2147/COPD.S96809.
    1. Sin DD, Leipsic J, Man SFP. CT in COPD: just a pretty picture or really worth a thousand words (or dollars)? Thorax. 2011 Sep;66(9):741–742. doi: 10.1136/thx.2011.161430.
    1. Rosenberg SR, Kalhan R, Mannino DM. Epidemiology of chronic obstructive pulmonary disease: prevalence, morbidity, mortality, and risk factors. Semin Respir Crit Care Med. 2015 Aug;36(4):457–469. doi: 10.1055/s-0035-1555607.
    1. Lee SJ, Kim SW, Kong KA, Ryu YJ, Lee JH, Chang JH. Risk factors for chronic obstructive pulmonary disease among never-smokers in Korea. Int J Chron Obstruct Pulmon Dis. 2015;10:497–506. doi: 10.2147/COPD.S77662. doi: 10.2147/COPD.S77662.
    1. Berndt A, Leme AS, Shapiro SD. Emerging genetics of COPD. EMBO Mol Med. 2012 Nov;4(11):1144–1155. doi: 10.1002/emmm.201100627.
    1. Cavaillès A, Brinchault-Rabin G, Dixmier A, Goupil F, Gut-Gobert C, Marchand-Adam S, Meurice J, Morel H, Person-Tacnet C, Leroyer C, Diot P. Comorbidities of COPD. Eur Respir Rev. 2013 Dec;22(130):454–475. doi: 10.1183/09059180.00008612.
    1. Chatila WM, Thomashow BM, Minai OA, Criner GJ, Make BJ. Comorbidities in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2008 May 01;5(4):549–555. doi: 10.1513/pats.200709-148ET.
    1. Shavelle RM, Paculdo DR, Kush SJ, Mannino DM, Strauss DJ. Life expectancy and years of life lost in chronic obstructive pulmonary disease: findings from the NHANES III Follow-up Study. Int J Chron Obstruct Pulmon Dis. 2009;4:137–148.
    1. Daldoul H, Denguezli M, Jithoo A, Gnatiuc L, Buist S, Burney P, Tabka Z, Harrabi I. Prevalence of COPD and tobacco smoking in Tunisia—results from the BOLD study. Int J Environ Res Public Health. 2013 Dec 17;10(12):7257–7271. doi: 10.3390/ijerph10127257.
    1. Alhamad EH, Alorainy HS, Lababidi H, Al-Hajjaj MS. The prevalence of chronic obstructive pulmonary disease in Riyadh, Saudi Arabia: a BOLD study. Int J Tuberc Lung Dis. 2015 Oct;19(10):1252–1257. doi: 10.5588/ijtld.14.0939.
    1. Danielsson P, Ólafsdóttir IS, Benediktsdóttir B, Gíslason T, Janson C. The prevalence of chronic obstructive pulmonary disease in Uppsala, Sweden—the Burden of Obstructive Lung Disease (BOLD) study: cross-sectional population-based study. Clin Respir J. 2012 Apr;6(2):120–127. doi: 10.1111/j.1752-699X.2011.00257.x.
    1. Rothman RJ, Greenland S, Lash TL. Modern Epidemiology. Third Edition. Philadelphia: Lippincott-Williams & Wilkins Publishers; 2008.
    1. World Health Organization The WHO country health profile of Kazakhstan. [2017-05-14].
    1. Buist AS, Vollmer WM, Sullivan SD, Weiss KB, Lee TA, Menezes AMB, Crapo RO, Jensen RL, Burney PGJ. The Burden of Obstructive Lung Disease Initiative (BOLD): rationale and design. COPD. 2005 Jun;2(2):277–283.
    1. Ford ES, Mannino DM, Wheaton AG, Giles WH, Presley-Cantrell L, Croft JB. Trends in the prevalence of obstructive and restrictive lung function among adults in the United States: findings from the National Health and Nutrition Examination surveys from 1988-1994 to 2007-2010. Chest. 2013 May;143(5):1395–1406. doi: 10.1378/chest.12-1135.
    1. Lohr SL. Sampling: Design and Analysis. 2nd Edition. Boston: Cengage Learning; 2010.
    1. Hoving C, Mudde AN. Effect of recruitment method and setting on the composition of samples consisting of adult smokers. Patient Educ Couns. 2007 Jan;65(1):79–86. doi: 10.1016/j.pec.2006.05.008.
    1. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J. Standardisation of spirometry. Eur Respir J. 2005 Aug;26(2):319–338. doi: 10.1183/09031936.05.00034805.
    1. Beigelman-Aubry C. Advanced chest imaging. [2017-07-06]. .
    1. Bhalla M, Turcios N, Aponte V, Jenkins M, Leitman BS, McCauley DI, Naidich DP. Cystic fibrosis: scoring system with thin-section CT. Radiology. 1991 Jun;179(3):783–788. doi: 10.1148/radiology.179.3.2027992.
    1. Tulek B, Kivrak AS, Ozbek S, Kanat F, Suerdem M. Phenotyping of chronic obstructive pulmonary disease using the modified Bhalla scoring system for high-resolution computed tomography. Can Respir J. 2013;20(2):91–96.
    1. Stanford Medicine 25. [2017-07-06]. Pulmonary exam: percussion and inspection .
    1. Stanford Medicine 25. [2017-01-25]. Cardiac second sounds .
    1. American Thoracic Society ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002 Jul 1;166(1):111–117. doi: 10.1164/ajrccm.166.1.at1102.
    1. Mahler DA, Horowitz MB. Perception of breathlessness during exercise in patients with respiratory disease. Med Sci Sports Exerc. 1994 Sep;26(9):1078–1081.
    1. Jones PW, Harding G, Berry P, Wiklund I, Chen W, Kline LN. Development and first validation of the COPD Assessment Test. Eur Respir J. 2009 Sep;34(3):648–654. doi: 10.1183/09031936.00102509.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren